An Evaluation of Folic Acid to Improve Endothelial Sensitivity to Shear Stress in Seniors
1 other identifier
interventional
44
1 country
1
Brief Summary
The purpose of this study is to evaluate if folic acid improves endothelial sensitivity to shear stress in post-menopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2019
CompletedFirst Posted
Study publicly available on registry
July 11, 2019
CompletedStudy Start
First participant enrolled
September 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2024
CompletedDecember 12, 2024
December 1, 2024
4.6 years
July 3, 2019
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endothelial sensitivity to shear rate
Change in brachial artery diameter for given levels of shear rate during rhythmic handgrip exercise
Measured 2 hours after placebo or folic acid consumption
Secondary Outcomes (1)
Neurovascular transduction
Measured 2 hours after placebo or folic acid consumption
Study Arms (2)
Placebo treatment
PLACEBO COMPARATORParticipant will be asked to ingest a placebo capsule.
Folic Acid
EXPERIMENTALParticipant will be asked to ingest a capsule containing 5 mg of folic acid.
Interventions
Eligibility Criteria
You may qualify if:
- ≥ 1-year amenorrhea
- Body mass index ≤ 30 kg/m2
- Resting blood pressure \< 140 / \< 90 mmHg
- Non-smoker (≥ 1-year)
You may not qualify if:
- Diagnosis of cardiac, vascular, respiratory, neurological or metabolic disease and/or a prescription of medications for the treatment of such diseases.
- For female participants, hormonal replacement therapy within 1 year of enrolment in the study.
- For female participants, having undergone an ovariectomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiovascular Prevention and Rehabilitation Centre of the Montreal Heart Institute
Montreal, Quebec, H1T1N6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 3, 2019
First Posted
July 11, 2019
Study Start
September 9, 2019
Primary Completion
April 3, 2024
Study Completion
April 3, 2024
Last Updated
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
All individual data will be de-identified and available to the public through publications, media articles and conference presentations